Business NewsPR NewsWire • Cephalon and Mesoblast Enter Into Strategic Alliance to Develop and Commercialize Novel Therapeutic Products for Regenerative Medicine

Cephalon and Mesoblast Enter Into Strategic Alliance to Develop and Commercialize Novel Therapeutic Products for Regenerative Medicine

Cephalon and Mesoblast Enter Into Strategic Alliance to Develop and Commercialize Novel Therapeutic Products for Regenerative Medicine

FRAZER, Pa. and MELBOURNE, Australia, Dec. 7, 2010 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) and Mesoblast Limited (ASX: MSB; USADR: MBLTY), today announced they have entered into a strategic alliance to develop and commercialize novel adult Mesenchymal Precursor Stem Cell (MPC) therap

View More : http://www.prnewswire.com/news-releases/cephalon-and-mesoblast-enter-into-strategic-alliance-to-develop-and-commercializ...
Releted News by prnewswire
7.8 Millones de Empresas Cuyos Propietarios son Mujeres, Generan Ingresos de $1.2 Billones en el 2007
Amdocs Limited Files Fiscal 2010 Annual Report
Cephalon and Mesoblast Enter Into Strategic Alliance to Develop and Commercialize Novel Therapeutic Products for Regenerative Medicine